EOLS

Evolus, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Moatazedi DavidDirector, Officer: See Remarks
$65k13.7k shares
SellMar 20, 2026
$4.75
--
Avelar RuiSee Remarks
$15k3.1k shares
SellMar 20, 2026
$4.75
--
Moatazedi DavidDirector, Officer: See Remarks
$571k116.7k shares
SellMar 17, 2026
$4.89
--
Avelar RuiSee Remarks
$147k30k shares
SellMar 17, 2026
$4.89
--
Moatazedi DavidDirector, Officer: See Remarks
$75k10.5k shares
SellDec 22, 2025
$7.15
--
Avelar RuiSee Remarks
$16k2.3k shares
SellDec 22, 2025
$7.15
--

News

businesswire.comEvolus to Participate in The Jefferies Global Healthcare Conferencebusinesswire.comMay 19businesswire.comEvolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europebusinesswire.comMay 11seekingalpha.comEvolus, Inc. (EOLS) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 5zacks.comEvolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimateszacks.comMay 4businesswire.comEvolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlookbusinesswire.comMay 4